Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS)

X
Trial Profile

The Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS)

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Jul 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Somatropin (Primary)
  • Indications Growth disorders; Short stature; Somatotropin deficiency; Turner's syndrome
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms GeNeSIS
  • Sponsors Eli Lilly and Company
  • Most Recent Events

    • 20 Mar 2018 Results presented at The 100th Annual Meeting of the Endocrine Society
    • 19 Apr 2017 New trial record
    • 04 Apr 2017 Results (n=5076) analysing near adult height gains in Somatropin treated children with growth disorders from the GeNeSIS observational study, presented at The 99th Annual Meeting of the Endocrine Society.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top